News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sumitomo Pharmaceuticals Co. Ltd. To Transfer Its Antitumor Antibiotic Sales To Nippon Kayaku Co., Ltd.


10/19/2005 5:12:24 PM

Tokyo (JCNN) - Sumitomo Pharmaceuticals has announced that it has signed a memorandum on the transfer of sales of its proprietary antitumor drug Calsed with Nippon Kayaku (TSE: 4272).

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES